A drug dubbed the "female Viagra" is set to be approved by a US watchdog this week - paving the way for its arrival elsewhere around the world.
Industry experts claim flibanserin could be given the green light within days, making it the first officially sanctioned drug for low female sex drive on the market.
Unlike its male equivalent, the drug combats a flagging libido not by targeting the genitals but the pleasure centre of a woman's brain, with women who took the pill every day in trials having sex more frequently and enjoying it more.
However, the drug has been plagued by safety fears.
Large-scale trials by manufacturers Sprout Pharmaceuticals found the pill - originally created as an antidepressant - was linked to side effects such as fainting and low blood pressure, nausea, fatigue, drowsiness and insomnia.